Drugs,Code,Library,Selected,preset_ARChetype Disease CRF_Dengue,preset_ARChetype Syndromic CRF_ARI,Value,Language Speaker Reviewed,Clinical Language Speaker Reviewed
Abatacept (Orencia), L04AA24  , ATC     , ,,,1,,
Adalimumab (Humira), L04AB04  , ATC     ,1,,,2,,
"Alemtuzumab (Campath, Lemtrada)", L04AA34, ATC     ,,1.0,,3,,
anakinra,L04AC03,ATC,,,,4,,
"Azatioprina (Imuran, Azasan)", L04AX01  , ATC     ,1,1.0,1.0,5,,
Basiliximab (Simulect), L04AC02, ATC     , ,,,6,,
Belatacept (Nulojix), L04AA28, ATC     , ,,,7,,
"Ciclosporina (Neoral, Sandimmune, Gengraf)", L04AD01  , ATC     ,1,1.0,,8,,
Etanercept (Enbrel), L04AB01  , ATC     ,1,,,9,,
"Everolimus (Afinitor, Zortress)", L04AA18  , ATC     , ,1.0,,10,,
"Infliximab (Avsola, Inflectra, Remicade)", L04AB02  , ATC     ,1,,,11,,
Leflunomida (Arava), L04AA13  , ATC     , ,,,12,,
Mercaptopurina (Purixan),L01BB02,ATC,,,,13,,
"Metotrexato (Trexall, Rasuvo, Otrexup)",L04AX03  ,ATC     ,1,1.0,1.0,14,,
Micofenolato de mofetilo (CellCept), L04AA06  , ATC     ,1,1.0,,15,,
Ácido micofenólico (Myfortic), L04AA06, ATC     ,1,,1.0,16,,
Natalizumab (Tysabri), L04AA23  , ATC     , ,,,17,,
Nivolumab (Opdivo),L01FF02,ATC,,,,18,,
"Rituximab (Rituxan, MabThera)",L01FA01 , ATC     ,1,1.0,1.0,19,,
Sarilumab (Kevzara), L04AC14, ATC     ,1,,,20,,
Secukinumab (Cosentyx), L04AC10  , ATC     , ,,,21,,
Sirolimus (Rapamune), L04AA10  , ATC     , ,1.0,,22,,
"Tacrolimus (Prograf, Advagraf, Protopic)", L04AD02  , ATC     ,1,1.0,,23,,
Talidomida (Thalomid),L04AX02,ATC,,,,24,,
Tocilizumab (Actemra), L04AC07  , ATC     ,1,,1.0,25,,
Ustekinumab (Stelara), L04AC05  , ATC     , ,,,26,,
Vedolizumab (Entyvio), L04AA33, ATC     , ,,,27,,
